Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity

HIGHLIGHTS

• who: Lino Mu00f6hrmann from the Research (MASTER) precision oncology program between May , and July , with follow-up until June, All , patients had a CUP diagnosis according to their referring oncologists. Clinical data for cohort selection, description and analysis was obtained from the National Center for Tumor Diseases (NCT) Heidelberg and Dresden, as well as from six other comprehensive cancer centers (CCCs) of the German Cancer Consortium (DKTK). The DKTK network includes ten CCCs at eight sites (Berlin, Dresden, Essen/Du00fcsseldorf, Frankfurt/Mainz, Freiburg, Heidelberg, Munich, Tu00fcbingen). Demographic data, histopathological diagnosis, location of metastases at the time of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.